tiprankstipranks
Adma Biologics sees FY26 revenue at least $605M
PremiumThe FlyAdma Biologics sees FY26 revenue at least $605M
9h ago
Adma Biologics options imply 11.5% move in share price post-earnings
Premium
The Fly
Adma Biologics options imply 11.5% move in share price post-earnings
11h ago
Options Volatility and Implied Earnings Moves Today, March 03, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 03, 2025
19h ago
Adma Biologics reports preliminary FY24 revenue $417M-$425M, consensus $423.19M
PremiumThe FlyAdma Biologics reports preliminary FY24 revenue $417M-$425M, consensus $423.19M
2M ago
Adma Biologics sees FY25 revenue $485M, consensus $486.79M
Premium
The Fly
Adma Biologics sees FY25 revenue $485M, consensus $486.79M
2M ago
Adma Biologics announces partial paydown of senior term loan credit facility
Premium
The Fly
Adma Biologics announces partial paydown of senior term loan credit facility
2M ago
Adma Biologics reports Q3 EPS 15c, consensus 13c
PremiumThe FlyAdma Biologics reports Q3 EPS 15c, consensus 13c
4M ago
Adma Biologics options imply 13.3% move in share price post-earnings
Premium
The Fly
Adma Biologics options imply 13.3% move in share price post-earnings
4M ago
Is ADMA a Buy, Before Earnings?
Premium
Pre-Earnings
Is ADMA a Buy, Before Earnings?
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100